2008
DOI: 10.1016/j.vetmic.2008.02.018
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

27
98
7
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 99 publications
(135 citation statements)
references
References 23 publications
27
98
7
3
Order By: Relevance
“…On the other hand, the resistance to marbofloxacin found in this study is lower than the resistance rates of between 25% and 49% recorded in other studies (McKAY et al, 2007;RUBIN et al, 2008;MÜLLER and HOM, 2009). The main reason for this is probably the fact that marbofloxacin is registered in Croatia only for topical treatment of otitis externa.…”
Section: Discussioncontrasting
confidence: 81%
“…On the other hand, the resistance to marbofloxacin found in this study is lower than the resistance rates of between 25% and 49% recorded in other studies (McKAY et al, 2007;RUBIN et al, 2008;MÜLLER and HOM, 2009). The main reason for this is probably the fact that marbofloxacin is registered in Croatia only for topical treatment of otitis externa.…”
Section: Discussioncontrasting
confidence: 81%
“…MICs of the following 16 antimicrobials, amikacin (AMI), ampicillin (AMP), amoxicillin/clavulanic acid (AUG), cefoxitin (FOX), ceftiofur (XNL), ceftriaxone (AXO), cephalothin (CEP), chloramphenicol (CHL), ciprofloxacin (CIP), gentamicin (GEN), kanamycin (KAN), nalidixic acid (NAL), streptomycin (STR), sulfamethoxazole (SMX), tetracycline (TET) and trimethoprim/sulfamethoxazole (SXT), and 8 fluoroquinolones, ciprofloxacin (CIP), danofloxacin (DANO), difloxacin (DIF), enrofloxacin (ENRO), gatifloxacin (GAT), levofloxacin (LEVO), marbofloxacin (MARB) and orbifloxacin (ORB) were determined using the Sensititre susceptibility system according to the manufacturer's instructions (Trek Diagnostic Systems Inc., Independence, OH, USA). For those drugs that lacked specific interpretive criteria, CLSI breakpoints for Enterobacteriaceae were used [43]. E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as controls for antimicrobial susceptibility testing.…”
Section: Antimicrobial Susceptibility Testingmentioning
confidence: 99%
“…However, panaminoglycoside resistance e.g., gentamicin, spectinomycin, streptomycin and amikacin has been increasingly reported in the P. aeruginosa dog and cat isolates [18,19,23]. Such resistance has been clarified to be predominantly due to a poorly understood mechanism namely "impermeability resistance" as a consequence of diminished drug uptake and/or accumulation [21,31].…”
mentioning
confidence: 99%